3.95 USD
+0.1 (+2.6%)
We assign a fundamental rating of 3 out of 10 to CCEL. CCEL was compared to 101 industry peers in the Health Care Providers & Services industry. There are concerns on the financial health of CCEL while its profitability can be described as average. CCEL has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
CCEL had negative earnings in the past year.
In the past year CCEL had a positive cash flow from operations.
CCEL had positive earnings in 4 of the past 5 years.
Each year in the past 5 years CCEL had a positive operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of -0.75%, CCEL is in line with its industry, outperforming 46.53% of the companies in the same industry.
CCEL has a Return On Invested Capital of 7.64%. This is in the better half of the industry: CCEL outperforms 72.28% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CCEL is in line with the industry average of 9.22%.
The last Return On Invested Capital (7.64%) for CCEL is above the 3 year average (7.61%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.75% | ||
| ROE | N/A | ||
| ROIC | 7.64% |
ROA(3y)-3.55%
ROA(5y)0.12%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)7.61%
ROIC(5y)11.38%
1.3 Margins
CCEL's Profit Margin has declined in the last couple of years.
CCEL has a better Operating Margin (13.63%) than 83.17% of its industry peers.
CCEL's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 77.07%, CCEL belongs to the top of the industry, outperforming 91.09% of the companies in the same industry.
In the last couple of years the Gross Margin of CCEL has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 13.63% | ||
| PM (TTM) | N/A | ||
| GM | 77.07% |
OM growth 3Y-12.93%
OM growth 5Y-12.62%
PM growth 3Y-44.14%
PM growth 5Y-29.46%
GM growth 3Y2.95%
GM growth 5Y1.88%
2. Health
2.1 Basic Checks
CCEL has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
CCEL has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, CCEL has more shares outstanding
The debt/assets ratio for CCEL has been reduced compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of 0.07, we must say that CCEL is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.07, CCEL is doing worse than 79.21% of the companies in the same industry.
The Debt to FCF ratio of CCEL is 1.36, which is an excellent value as it means it would take CCEL, only 1.36 years of fcf income to pay off all of its debts.
CCEL has a better Debt to FCF ratio (1.36) than 88.12% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 1.36 | ||
| Altman-Z | 0.07 |
ROIC/WACC0.67
WACC11.49%
2.3 Liquidity
CCEL has a Current Ratio of 0.63. This is a bad value and indicates that CCEL is not financially healthy enough and could expect problems in meeting its short term obligations.
CCEL has a worse Current ratio (0.63) than 84.16% of its industry peers.
A Quick Ratio of 0.60 indicates that CCEL may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.60, CCEL is doing worse than 82.18% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.63 | ||
| Quick Ratio | 0.6 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 94.34% over the past year.
Measured over the past years, CCEL shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -29.04% on average per year.
Looking at the last year, CCEL shows a decrease in Revenue. The Revenue has decreased by -0.29% in the last year.
Measured over the past years, CCEL shows a small growth in Revenue. The Revenue has been growing by 0.11% on average per year.
EPS 1Y (TTM)94.34%
EPS 3Y-41.85%
EPS 5Y-29.04%
EPS Q2Q%-30.77%
Revenue 1Y (TTM)-0.29%
Revenue growth 3Y3.46%
Revenue growth 5Y0.11%
Sales Q2Q%-2.99%
3.2 Future
Based on estimates for the next years, CCEL will show a very negative growth in Earnings Per Share. The EPS will decrease by -202.32% on average per year.
Based on estimates for the next years, CCEL will show a decrease in Revenue. The Revenue will decrease by -3.22% on average per year.
EPS Next Y87%
EPS Next 2Y-202.32%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-1.55%
Revenue Next 2Y-3.22%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
CCEL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year CCEL is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
89.11% of the companies in the same industry are more expensive than CCEL, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, CCEL is valued cheaper than 97.03% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 5.15 | ||
| EV/EBITDA | 6.25 |
4.3 Compensation for Growth
A cheap valuation may be justified as CCEL's earnings are expected to decrease with -202.32% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-202.32%
EPS Next 3YN/A
5. Dividend
5.1 Amount
CCEL has a Yearly Dividend Yield of 21.35%, which is a nice return.
Compared to an average industry Dividend Yield of 2.47, CCEL pays a better dividend. On top of this CCEL pays more dividend than 100.00% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.32, CCEL pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 21.35% |
5.2 History
CCEL has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
The earnings of CCEL are negative and hence is the payout ratio. CCEL will probably not be able to sustain this dividend level.
DP-1109.12%
EPS Next 2Y-202.32%
EPS Next 3YN/A
NYSEARCA:CCEL (12/4/2025, 4:10:03 PM)
3.95
+0.1 (+2.6%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners7.28%
Inst Owner Change-0.69%
Ins Owners40.67%
Ins Owner Change2.25%
Market Cap31.84M
Revenue(TTM)31.75M
Net Income(TTM)-473.50K
Analysts43.33
Price Target8.67 (119.49%)
Short Float %0.13%
Short Ratio0.82
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 21.35% |
Yearly Dividend0.25
Dividend Growth(5Y)N/A
DP-1109.12%
Div Incr Years1
Div Non Decr Years1
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)227.45%
Min EPS beat(2)178.43%
Max EPS beat(2)276.47%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-3.61%
Min Revenue beat(2)-3.88%
Max Revenue beat(2)-3.33%
Revenue beat(4)0
Avg Revenue beat(4)-2.41%
Min Revenue beat(4)-3.88%
Max Revenue beat(4)-0.9%
Revenue beat(8)0
Avg Revenue beat(8)-2.16%
Revenue beat(12)2
Avg Revenue beat(12)-0.97%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-125%
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.71%
Revenue NY rev (1m)-1.42%
Revenue NY rev (3m)-1.42%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 1 | ||
| P/FCF | 5.15 | ||
| P/OCF | 5.01 | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | 6.25 |
EPS(TTM)-0.06
EYN/A
EPS(NY)-0.43
Fwd EYN/A
FCF(TTM)0.77
FCFY19.42%
OCF(TTM)0.79
OCFY19.96%
SpS3.94
BVpS-1.84
TBVpS-2.19
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.75% | ||
| ROE | N/A | ||
| ROCE | 9.68% | ||
| ROIC | 7.64% | ||
| ROICexc | 8.24% | ||
| ROICexgc | 8.84% | ||
| OM | 13.63% | ||
| PM (TTM) | N/A | ||
| GM | 77.07% | ||
| FCFM | 19.48% |
ROA(3y)-3.55%
ROA(5y)0.12%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)7.61%
ROIC(5y)11.38%
ROICexc(3y)7.98%
ROICexc(5y)14.72%
ROICexgc(3y)8.63%
ROICexgc(5y)16.85%
ROCE(3y)9.64%
ROCE(5y)14.41%
ROICexgc growth 3Y-17.95%
ROICexgc growth 5Y-25.17%
ROICexc growth 3Y-16.74%
ROICexc growth 5Y-23.68%
OM growth 3Y-12.93%
OM growth 5Y-12.62%
PM growth 3Y-44.14%
PM growth 5Y-29.46%
GM growth 3Y2.95%
GM growth 5Y1.88%
F-Score7
Asset Turnover0.5
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 1.36 | ||
| Debt/EBITDA | 1.54 | ||
| Cap/Depr | 17.31% | ||
| Cap/Sales | 0.54% | ||
| Interest Coverage | 2.13 | ||
| Cash Conversion | 119.5% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.63 | ||
| Quick Ratio | 0.6 | ||
| Altman-Z | 0.07 |
F-Score7
WACC11.49%
ROIC/WACC0.67
Cap/Depr(3y)548.95%
Cap/Depr(5y)370.25%
Cap/Sales(3y)23.15%
Cap/Sales(5y)15.23%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)94.34%
EPS 3Y-41.85%
EPS 5Y-29.04%
EPS Q2Q%-30.77%
EPS Next Y87%
EPS Next 2Y-202.32%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-0.29%
Revenue growth 3Y3.46%
Revenue growth 5Y0.11%
Sales Q2Q%-2.99%
Revenue Next Year-1.55%
Revenue Next 2Y-3.22%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-5.52%
EBIT growth 3Y-9.92%
EBIT growth 5Y-12.52%
EBIT Next Year22.6%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y112.76%
FCF growth 3Y-15.98%
FCF growth 5Y-8.62%
OCF growth 1Y-20.62%
OCF growth 3Y-8.81%
OCF growth 5Y-1.01%
CRYO-CELL INTL INC / CCEL FAQ
What is the fundamental rating for CCEL stock?
ChartMill assigns a fundamental rating of 3 / 10 to CCEL.
Can you provide the valuation status for CRYO-CELL INTL INC?
ChartMill assigns a valuation rating of 2 / 10 to CRYO-CELL INTL INC (CCEL). This can be considered as Overvalued.
Can you provide the profitability details for CRYO-CELL INTL INC?
CRYO-CELL INTL INC (CCEL) has a profitability rating of 5 / 10.
What is the financial health of CRYO-CELL INTL INC (CCEL) stock?
The financial health rating of CRYO-CELL INTL INC (CCEL) is 3 / 10.